{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:29:49Z","timestamp":1777508989280,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Anaesthesia and Pain Medicine"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","plefa.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.plefa.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:30:24Z","timestamp":1507833024000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans"],"prefix":"10.1016","volume":"127","author":[{"given":"Tomas","family":"Corcoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"O\u2019Loughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Barden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor A.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.plefa.2017.10.003_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/ars.2005.7.202","article-title":"Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension","volume":"7","author":"Fessel","year":"2005","journal-title":"Antioxd. Redox Signal."},{"issue":"26","key":"10.1016\/j.plefa.2017.10.003_bib2","doi-asserted-by":"crossref","first-page":"16713","DOI":"10.1073\/pnas.252649099","article-title":"Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension","volume":"99","author":"Fessel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.plefa.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1750-3639.2005.tb00511.x","article-title":"The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation","volume":"15","author":"Roberts","year":"2005","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.plefa.2017.10.003_bib4","article-title":"Hyperbaric oxygen for carbon monoxide poisoning","author":"Buckley","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.plefa.2017.10.003_bib5","first-page":"29","article-title":"Hyperbaric programs in the United States: locations and capabilities of treating decompression sickness, arterial gas embolisms, and acute carbon monoxide poisoning: survey results","volume":"43","author":"Chin","year":"2016","journal-title":"Undersea Hyperb. Med."},{"issue":"4","key":"10.1016\/j.plefa.2017.10.003_bib6","article-title":"Hyperbaric oxygen therapy for late radiation tissue injury","author":"Bennett","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.plefa.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ejvs.2014.03.005","article-title":"Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review","volume":"47","author":"Stoekenbroek","year":"2014","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"2","key":"10.1016\/j.plefa.2017.10.003_bib8","article-title":"Hyperbaric oxygen therapy for thermal burns","author":"Villanueva","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.plefa.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00005373-198707000-00013","article-title":"Adjunctive hyperbaric-oxygen therapy in the treatment of chronic refractory osteomyelitis","volume":"27","author":"Esterhai","year":"1987","journal-title":"J. Trauma-Inj. Infect. Crit. Care"},{"issue":"25","key":"10.1016\/j.plefa.2017.10.003_bib10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM199606203342506","article-title":"Medical progress - hyperbaric-oxygen therapy","volume":"334","author":"Tibbles","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.plefa.2017.10.003_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1152\/japplphysiol.91004.2008","article-title":"Oxidative stress is fundamental to hyperbaric oxygen therapy","volume":"106","author":"Thom","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.plefa.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products ((F-2-isoprostanes)) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.plefa.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.freeradbiomed.2011.06.026","article-title":"Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery","volume":"51","author":"Corcoran","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.plefa.2017.10.003_bib14","unstructured":"B. Jann, nlcheck: Stata module to check linearity assumption after model estimation, 2008 \u3008http:\/\/ideasrepecorg\/\u3009."},{"issue":"7166","key":"10.1016\/j.plefa.2017.10.003_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/bmj.317.7166.1140","article-title":"ABC of oxygen - hyperbaric oxygen therapy","volume":"317","author":"Leach","year":"1998","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.plefa.2017.10.003_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.33549\/physiolres.931139","article-title":"Early and late effects of hyperbaric oxygen treatment on oxidative stress parameters in diabetic patients","volume":"57","author":"Gurdol","year":"2008","journal-title":"Physiol. Res."},{"key":"10.1016\/j.plefa.2017.10.003_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2431-7-36","article-title":"The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study","volume":"7","author":"Rossignol","year":"2007","journal-title":"BMC Pediatr."},{"issue":"9","key":"10.1016\/j.plefa.2017.10.003_bib18","doi-asserted-by":"crossref","first-page":"e0163371","DOI":"10.1371\/journal.pone.0163371","article-title":"Antioxidant response of chronic wounds to hyperbaric oxygen therapy","volume":"11","author":"Sureda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2017.10.003_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.prostaglandins.2013.04.003","article-title":"Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans","volume":"107","author":"Galano","year":"2013","journal-title":"Prostaglandins Other Lipid\u00a0Mediators"},{"issue":"6","key":"10.1016\/j.plefa.2017.10.003_bib20","first-page":"419","article-title":"Structural alterations in adult rat carotid bodies exposed to hyperbaric oxygenation","volume":"37","author":"Leite","year":"2010","journal-title":"Undersea Hyperb. Med."},{"issue":"9","key":"10.1016\/j.plefa.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.freeradbiomed.2011.01.021","article-title":"Effects of spinal or general anesthesia on F(2)-isoprostanes and isofurans during ischemia\/reperfusion of the leg in patients undergoing knee replacement surgery","volume":"50","author":"Mas","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"13","key":"10.1016\/j.plefa.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.plefa.2017.10.003_bib23","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1089\/ars.2013.5527","article-title":"Statins as regulators of redox signaling in platelets","volume":"20","author":"Violi","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.plefa.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjhyper.2006.09.020","article-title":"Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients","volume":"20","author":"Fratta Pasini","year":"2007","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.plefa.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.amjhyper.2003.11.004","article-title":"The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat","volume":"17","author":"Zhang","year":"2004","journal-title":"Am. J. Hypertens."},{"issue":"11","key":"10.1016\/j.plefa.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archsurg.135.11.1293","article-title":"Effect of hyperoxia on vascular endothelial growth factor levels in a wound model","volume":"135","author":"Sheikh","year":"2000","journal-title":"Arch. Surg."},{"issue":"36","key":"10.1016\/j.plefa.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor 1 alpha (HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions - Its stabilization by hypoxia depends on redox-induced changes","volume":"272","author":"Salceda","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.plefa.2017.10.003_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr. Opin. Cell Biol."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327817301047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327817301047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T13:03:32Z","timestamp":1659618212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327817301047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"alternative-id":["S0952327817301047"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2017.10.003","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}